On the 10th, Eugene Investment & Securities analyzed that Hecto Innovation delivered an earnings surprise in the second quarter and is expected to continue setting record-high performance in the upcoming third quarter.


Researcher Park Jong-sun of Eugene Investment & Securities stated in a report on the day, “Hecto Innovation posted sales of 71.8 billion KRW and operating profit of 9.5 billion KRW in the second quarter of this year, representing a 9.2% increase in sales and a significant 53.4% increase in operating profit compared to the same period last year,” adding, “Compared to market expectations (sales of 69.4 billion KRW, operating profit of 7.9 billion KRW), sales exceeded by 3.4%, showing a similar level, but operating profit surpassed expectations by 20.5%, delivering an earnings surprise.”


Researcher Park noted, “A positive aspect of the second-quarter results is that Hecto Innovation has continuously maintained a growth trend by setting record-high quarterly sales for 13 consecutive quarters,” and analyzed, “Both Hecto Innovation headquarters and Hecto Financial drove performance growth with sales increasing by 8.8% and 15.4% respectively compared to the same period last year.”


He also explained that despite reinvestment in the development of functional ingredients by the subsidiary Hecto Healthcare, profitability improvement continues with a significant turnaround to black ink, which is positive.



He predicted, “The expected third-quarter consolidated results are sales of 75.9 billion KRW and operating profit of 13.5 billion KRW, representing increases of 13.8% and 14.2% respectively compared to the same period last year, continuing the record-high performance,” and judged, “With stable performance growth, the stock price is likely to shift to an upward trend.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing